Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Allogene Therapeutics (ALLO)
Technical Analysis Report for USA stock ALLO Allogene Therapeutics. Dated: 17 Jan 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ALLO Allogene Therapeutics then click here. or read Experts views on Allogene Therapeutics or Forecast & share price targets of Allogene Therapeutics
Allogene Therapeutics Opened at 1.87 and Closed at: 1.82, which is 0% of previous session's close. It moved within a range of 1.79 and 1.90
The session was a Bearish session with an average volume of 2222200, which is 0% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
A Dead cross was found 2 days back on short term averages
Support for tomorrow is 1.75 and resistance for tomorrow is 1.86
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.77, 1.73 resistance for tomorrow's hourly charts is 1.88, 1.95
10 Day SMA for Allogene Therapeutics (ALLO) is 1.99 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Allogene Therapeutics (ALLO) is 2.07 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Allogene Therapeutics (ALLO) is 2.28 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 2.48 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Allogene Therapeutics is 2.64 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Allogene Therapeutics is at 2.07 and 200 DMA is at 2.64, while 50 DMA and 100 DMA are at 2.28 and 2.48 respectively
Allogene Therapeutics (ALLO) moving average of 20 SMA is at 2.07 and 20 EMA is at 2.04
Date | Closing Price | 20 SMA | 20 EMA |
17 Fri Jan | 1.82 | 2.07 | 2.04 |
17 Fri Jan | 1.82 | 2.07 | 2.06 |
16 Thu Jan | 1.84 | 2.08 | 2.08 |
15 Wed Jan | 1.87 | 2.08 | 2.11 |
14 Tue Jan | 1.92 | 2.09 | 2.14 |
13 Mon Jan | 1.95 | 2.1 | 2.16 |
Allogene Therapeutics (ALLO) moving average of 50 SMA is at 2.28 and 50 EMA is at 2.19
Date | Closing Price | 50 SMA | 50 EMA |
17 Fri Jan | 1.82 | 2.28 | 2.19 |
17 Fri Jan | 1.82 | 2.29 | 2.21 |
16 Thu Jan | 1.84 | 2.31 | 2.23 |
15 Wed Jan | 1.87 | 2.33 | 2.25 |
14 Tue Jan | 1.92 | 2.34 | 2.27 |
13 Mon Jan | 1.95 | 2.35 | 2.28 |
Allogene Therapeutics (ALLO) moving average of 100 SMA is at 2.48 and 100 EMA is at 2.44
Date | Closing Price | 100 SMA | 100 EMA |
17 Fri Jan | 1.82 | 2.48 | 2.44 |
17 Fri Jan | 1.82 | 2.49 | 2.45 |
16 Thu Jan | 1.84 | 2.5 | 2.46 |
15 Wed Jan | 1.87 | 2.51 | 2.47 |
14 Tue Jan | 1.92 | 2.51 | 2.48 |
13 Mon Jan | 1.95 | 2.52 | 2.49 |
Allogene Therapeutics (ALLO) moving average of 200 SMA is at 2.64 and 200 EMA is at 2.68
Date | Closing Price | 200 SMA | 200 EMA |
17 Fri Jan | 1.82 | 2.64 | 2.68 |
17 Fri Jan | 1.82 | 2.65 | 2.69 |
16 Thu Jan | 1.84 | 2.66 | 2.7 |
15 Wed Jan | 1.87 | 2.67 | 2.71 |
14 Tue Jan | 1.92 | 2.69 | 2.72 |
13 Mon Jan | 1.95 | 2.7 | 2.73 |
Zimmer Biomet has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Zimmer Biomet, about 9.24% more returns!
Allogene Therapeutics has performed better than Enzo Biochem in short term. Holding Allogene Therapeutics could be a better choice for now!
Allogene Therapeutics has performed better than Charles River in short term. Holding Allogene Therapeutics could be a better choice for now!
Verona Pharma has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Verona Pharma, about 21.27% more returns!
Spero Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Spero Therapeutics, about 5.58% more returns!
Sage Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Sage Therapeutics, about 36.82% more returns!
Allogene Therapeutics has performed better than Radius Health in short term. Holding Allogene Therapeutics could be a better choice for now!
Phibro Animal has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Phibro Animal, about 2.88% more returns!
Orthofix Medical has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Orthofix Medical, about 11.29% more returns!
Allogene Therapeutics has performed better than Marker Therapeutics in short term. Holding Allogene Therapeutics could be a better choice for now!
Incyte Corporation has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Incyte Corporation, about 9.66% more returns!
Amicus Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Amicus Therapeutics, about 2.3% more returns!
Allogene Therapeutics has performed better than Fennec Pharmaceuticals in short term. Holding Allogene Therapeutics could be a better choice for now!
Allogene Therapeutics has performed better than Eyenovia Inc in short term. Holding Allogene Therapeutics could be a better choice for now!
Editas Medicine has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Editas Medicine, about 4.27% more returns!
Allogene Therapeutics has performed better than Anavex Life in short term. Holding Allogene Therapeutics could be a better choice for now!
Allogene Therapeutics has performed better than Aquestive Therapeutics in short term. Holding Allogene Therapeutics could be a better choice for now!
Anika Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Anika Therapeutics, about 5.68% more returns!
Allogene Therapeutics Technical analysis of indicators
Price action analysis of Allogene Therapeutics (ALLO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Allogene Therapeutics in short term and the sell signal is strong.
Allogene Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Allogene Therapeutics in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Allogene Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.02 and Allogene Therapeutics ALLO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics ALLO stock. Volume based technical analysis of Allogene Therapeutics ALLO stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ALLO Allogene Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALLO Experts View which covers a lot of information including buying and selling signals
ALLO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Allogene Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance